Brock Kelly A, Doucette William R
Chicago College of Pharmacy, Midwestern University, Downers Grove, Ill, USA.
J Am Pharm Assoc (2003). 2004 May-Jun;44(3):358-65. doi: 10.1331/154434504323063995.
To determine the degree of collaboration in a limited number of pharmacist-physician professional relationships and identify variables important in establishing collaboration between pharmacists and physicians.
A multicase design, using a personal interview and a mailed survey.
Iowa.
Pharmacists in 10 community pharmacies and physicians with whom they collaborated.
Two researchers independently judged the stage of collaboration for each case and the level of effect each influence variable had on the development of pharmacist-physician collaboration.
Using the Collaborative Working Relationship Model, nine indicators of collaboration were assessed. In addition, influence variables were studied, which included individual, context, and exchange characteristics believed to affect the development of collaborative working relationships between pharmacists and physicians.
A Perrealt-Leigh reliability index of 0.89 was calculated as an estimate of interrater reliability of the judgments of nine indicators of collaboration. Four pharmacies were rated as having achieved early-stage collaboration, while six pharmacies were at late-stage collaboration. A high level of joint care activities, care communication, and increased accessibility to the physician and to patient information characterized late-stage collaboration. Six variables, labeled as discriminating, helped distinguish between early-stage collaboration and late-stage collaboration: the development of bidirectional communication, caring for mutual patients, the ability to identify a win-win opportunity, adding value to the medical practice, physician convenience, and movement toward balanced dependence between the pharmacist and physician.
The development of collaboration between pharmacists and physicians is influenced by characteristics of exchanges occurring between them. Continued study of collaborative working relationships between physicians and pharmacists can assist health care practitioners in developing a team-based approach to patient care, improving the ability of pharmacists and physicians to work together to coordinate patient care.
确定有限数量的药剂师 - 医生专业关系中的合作程度,并识别在药剂师与医生之间建立合作关系中重要的变量。
采用多案例设计,运用个人访谈和邮寄调查。
爱荷华州。
10家社区药房的药剂师及其合作的医生。
两名研究人员独立判断每个案例的合作阶段以及每个影响变量对药剂师 - 医生合作发展的影响程度。
使用协作工作关系模型,评估九个合作指标。此外,研究了影响变量,包括个人、背景和交流特征,这些特征被认为会影响药剂师与医生之间协作工作关系的发展。
计算出佩雷尔特 - 利可靠性指数为0.89,作为对九个合作指标判断的评分者间可靠性的估计。四家药房被评为处于早期合作阶段,而六家药房处于后期合作阶段。高水平的联合护理活动、护理沟通以及增加医生和患者信息的可及性是后期合作的特征。六个被标记为有区分性的变量有助于区分早期合作和后期合作:双向沟通的发展、共同照顾患者、识别双赢机会的能力、为医疗实践增加价值、医生便利性以及药剂师与医生之间朝着平衡依赖的方向发展。
药剂师与医生之间合作关系的发展受到他们之间交流特征的影响。对医生与药剂师之间协作工作关系的持续研究可以帮助医疗保健从业者制定基于团队的患者护理方法,提高药剂师和医生共同协调患者护理的能力。